Corcept Therapeutics (CORT) Stock Price, Quote, News & History | Benzinga

Corcept Therapeutics Inc (CORT) Stock Price, Quote, News & History

CORTNASDAQ

Trade with Public

Trade with Public

$114.49

-2.44-2.09%

Last update: Aug 28, 12:00 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$117.14

Close

-

Volume / Avg.

218.62K / 1.10M

Day Range

$114.03 - $118.67

52 Wk Range

28.66 - 126.38

Market Cap

$12.38B

P/E Ratio

259.84

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

11.56%

Days to Cover

10.45

Recent Corcept Therapeutics Incorporated News

Stock Market Today: Microsoft Ignites Chip Rebound as SanDisk Jumps 24%

Microsoft's 43% cloud growth revived the AI trade and lifted chipmakers, but Meta's guidance miss and a 19-year high in 30-year yields capped the rebound.

Piero Cingari

Lam Research, Xerox, FormFactor, Microsoft And Other Big Stocks Moving Higher On Thursday

Dow Jones index gained 300 points, Lam Research Corp rose 20.1% after reporting strong financial results. Xerox, Columbus McKinnon, and other stocks recorded gains.

Avi Kapoor

Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares jumped 7.8% in pre-market trading.

Avi Kapoor

Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know

Corcept Therapeutics shares soared 21.95% after hours as strong quarterly results and raised guidance boosted investor confidence.

Mohd Haider

This Warner Bros Discovery Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday

Top Wall Street analysts changed outlook on several top stocks. See all changes on analyst ratings page.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

109.70M

Investing Cash Flow (TTM)

-21.90M

Financing Cash Flow (TTM)

-78.91M

Free Cash Flow (TTM)

106.92M

Capital Expenditure (TTM)

-2.78M

Net Change in Cash (TTM)

8.90M

Analyst Trends and Forecast

2

Mar

5

May

4

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$12.34B

PE Ratio (TTM)

259.84

PE Ratio (FWD)

59.52

PEG Ratio (TTM)

-

PS Ratio (TTM)

16.62

PB Ratio (TTM)

17.91

Earnings Yield % (TTM)

0.38%

Earnings Yield % (FWD)

1.68%

EV / EBITDA (TTM)

1398.43

Price / EBITDA (TTM)

1564.28

Price / Free Cash Flow (TTM)

129.11

Book Value / Share

$6.53

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$111.04M

Debt to Equity

0.01

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$117.14

Close

-

Volume / Avg.

218.62K / 1.10M

Day Range

$114.03 - $118.67

52 Wk Range

28.66 - 126.38

Market Cap

$12.38B

P/E Ratio

259.84

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

11.56%

Days to Cover

10.45

About

Sector

Health Care

Industry

Pharmaceuticals

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Corcept Therapeutics (CORT) stock?

A

You can purchase shares of Corcept Therapeutics (NASDAQ:CORT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Corcept Therapeutics (CORT) competitors?

A

Other companies in Corcept Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Corcept Therapeutics (CORT) stock?

A

Corcept Therapeutics has a consensus price target of $127.17.

Q

What is the current price for Corcept Therapeutics (CORT)?

A

The stock price for Corcept Therapeutics (NASDAQ: CORT) is $114.49 last updated August 28, 2026 at 12:00 PM EDT.

Q

Does Corcept Therapeutics (CORT) pay a dividend?

A

There are no upcoming dividends for Corcept Therapeutics.

Q

When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?

A

Corcept Therapeutics does not have any upcoming earnings scheduled.

Q

Is Corcept Therapeutics (CORT) going to split?

A

There is no upcoming split for Corcept Therapeutics.

Q

What sector and industry does Corcept Therapeutics (CORT) operate in?

A

Corcept Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.